Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Wino115on Jul 04, 2021 5:02pm
135 Views
Post# 33490960

RE:Help from this forum

RE:Help from this forumI'm afraid I'm not of much help on things like this given I'm no doctor. Not sure if he's mobile, but it never hurts to go to a large cancer-oriented hospital when you have a rare one. There is that one in Detroit in the TH1902 trial if he's close, or the centers in NY like Memorial Sloan Kettering, NYU cancer or Mount Sinai.  Boston has Dana Farber Cancer Inst and Mass General.  The benefit is that they see a large number of "odd" cancers and may have depth of experience. They also have the newest approaches. I'm not discounting Canada has some great centers like that, it's just that I don't know which are the cancer oriented research hospitals in Canada and he's likely consulted with the one hear him. Perhaps our friend on here dealing with his wife's ovarian knows the best Canadian ones for something rare like that. 

SABBOBCAT wrote: Hey team, I know we have a very knowledgeable following on this forum and I need your help. My neighbor (a father of 5) has bile duct cancer (cholangiocarcinoma) and it sounds like things aren't going well. Would something like TH1902 work for this type of cancer? At this point it would be a hailmary play, but thought I would ask as their doctor in Canada may not be aware of the US trials


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse